Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.69
-0.04 (-0.52%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $508.75 million as of April 25, 2025. Its market cap has increased by 58.64% in one year.
Market Cap
508.75M
Enterprise Value
820.57M
1-Year Change
58.64%
Ranking
Category
Stock Price
$7.69
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $508.75M, a decrease of -28.69%. That is a compound annual growth rate of -7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 511.39M | -25.49% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 765.38B |
| UnitedHealth Group | 388.57B |
| Johnson & Johnson | 372.44B |
| AbbVie | 318.77B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.27B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |